Showing results (21-30 of 171) with videos related to
Sort By:
Pageof 18
European Heart Journal|June 18, 2013
Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?Carlo PatronoJournal of Cardiovascular Pharmacology|June 21, 2006
The PGH-synthase system and isozyme-selective inhibitionCarlo PatronoCurrent Cardiology Reports|February 5, 2016
Cardiovascular Effects of Nonsteroidal Anti-inflammatory DrugsCarlo PatronoProceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed plateletsBianca Rocca, Paola Secchiero, Giovanni Ciabattoni, et al.Clinical and Translational Science|October 6, 2022
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulationGiovanna Petrucci, Alberto Giaretta, Paola Ranalli, et al.Blood|January 12, 2012
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug targetSilvia Pascale, Giovanna Petrucci, Alfredo Dragani, et al.Journal of the American College of Cardiology|September 30, 2017
Antiplatelet Agents for the Treatment and Prevention of Coronary AtherothrombosisCarlo Patrono, Joao Morais, Colin Baigent, et al.Molecular Interventions|March 28, 2006
Targeting PGE2 receptor subtypes rather than cyclooxygenases: a bridge over troubled water?Bianca RoccaEuropean Heart Journal|February 22, 2024
Thromboxane biosynthesis and future events in diabetes: the ASCEND trialGiovanna Petrucci, Georgina A Buck, Bianca Rocca, et al.Nature Reviews. Cardiology|June 28, 2019
Role of aspirin in primary prevention of cardiovascular diseaseCarlo Patrono, Colin BaigentPageof 18